Both in Pharmaceuticals
Sarepta Therapeutics, vs Xeris Biopharma Holdings
Over the past year SRPT returned −22.0% and XERS returned +7.3%; their daily moves had a correlation of 0.13.
SRPT −22.0% XERS +7.3%Growth of $1, one year, split-adjusted
| Metric | SRPT | XERS |
|---|---|---|
| Price | $19.06 | $10.63 |
| Market cap | $2.01B | $1.94B |
| Today | +2.80% | +2.66% |
| 1 month | +10.1% | +5.5% |
| 6 months | −17.2% | +66.8% |
| Year to date | −11.4% | +35.4% |
| 1 year | −22.0% | +7.3% |
| Revenue growth (YoY) | −34.3% | +28.7% |
| Gross margin | 62.8% | 86.4% |
| Net margin | −1.2% | −33.8% |
| P/E (TTM) | — | — |
| Price / sales | 1.0× | 5.8× |
| Net cash | -$59.1M | -$130.8M |
| Dividend yield | — | — |
| Volatility (60d) | 61.7% | 51.8% |
| Short % of float | 22.7% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).